Results 291 to 300 of about 166,832 (321)

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Nature, 2004
Edward Tuddenham, Johannes Oldenburg
exaly  

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Lancet, The, 2009
Vivek Y Reddy
exaly  

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine, 2009
Stuart J Connolly, Michael D Ezekowitz, Salim Yusuf   +2 more
exaly  

Warfarin

Reactions Weekly, 2022
openaire   +1 more source

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

New England Journal of Medicine, 2011
Manesh R Patel, Daniel E Singer, Werner Hacke   +2 more
exaly  

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Lancet, The, 2007
Jonathan Mant, Fd Richard Hobbs, Gregory Lip   +2 more
exaly  

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine, 2011
Christopher B Granger, John H Alexander, John J V Mcmurray   +2 more
exaly  

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

Lancet, The, 2010
Salim Yusuf, Michael D Ezekowitz, Antonio Dans   +2 more
exaly  

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation, 2014
Sam Schulman, Clive Kearon
exaly  

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine, 2013
Robert P Giugliano, Eugene Braunwald, Michael D Ezekowitz   +2 more
exaly